OpenScholar

Search results

71 results found

Erkin Kurganov, Ph.D.

Person: Research Scientist I

Erkin Kurganov is an electrophysiologist focusing on ion channel biophysics and physiology. Erkin earned his Ph.D. from SOKENDAI (The Graduate University for Advanced Studies) under the guidance of Prof. Makoto Tominaga in Japan. During his Ph.D. training, Erkin focused on temperature-evoked...

Pan Group

The Pan Group in the Stanley Center for Psychiatric Research focuses on translating emerging human genetics into biological insights that can be turned into potential novel therapeutics for major psychiatric illnesses including schizophrenia and bipolar disorders.

Ned Martenis

Person: Research Associate III

William “Ned” Martenis is a therapeutics group research associate affiliated with the Pan and Sheng labs, where he primarily develops, troubleshoots, and runs high-throughput assays designed to better understand psychiatric disease. Most prominently, Ned is working on a drug discovery project that...

Resources

Page

The Pan Lab has created PatchAnalytics, a cloud-based web application for automated analysis of SyncroPatch Data. PatchAnalytics Contributors: Lei A. Wang, Ziyue Zhu, David Zhou, David Baez, Yining Wang The Pan Lab has created IntelliSleepScorer, a software package with a graphic user interface for...

AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology

Publication: Manuscript

Tsimberidou, Apostolia-Maria. 2022. “AKT Inhibition in the Central Nervous System Induces Signaling Defects Resulting in Psychiatric Symptomatology.”

Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome

Publication: Journal Article

Hwang, Hongik, Matthew J. Szucs, Lei J. Ding, Andrew Allen, Xiaobai Ren, Henny Haensgen, Fan Gao, et al. 2021. “Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome”. Biological Psychiatry 89 (3): 256-69.

Yining Wang

Person: Computational Associate I

Yining is a Computational Associate. She majored in Data Science and Computer Science.

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

Publication: Journal Article

McCamphill, Patrick, Laura Stoppel, Rebecca Senter, Michael Lewis, Arnold Heynen, David Stoppel, Vinay Sridhar, et al. 2020. “Selective Inhibition of Glycogen Synthase Kinase 3α Corrects Pathophysiology in a Mouse Model of Fragile X Syndrome”. Science Translational Medicine 12 (544).

Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia

Publication: Journal Article

Wagner, Florence, Lina Benajiba, Arthur Campbell, Michel We{\"ıwer, Joshua Sacher, Jennifer Gale, Linda Ross, et al. 2018. “Exploiting an Asp-Glu ‘switch’ in Glycogen Synthase Kinase 3 to Design Paralog-Selective Inhibitors for Use in Acute Myeloid Leukemia”. Science Translational Medicine 10 (431).

Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons

Publication: Journal Article

Lu, Congyi, Xi Shi, Andrew Allen, David Baez-Nieto, Alexandria Nikish, Neville Sanjana, and Jen Pan. 2019. “Overexpression of NEUROG2 and NEUROG1 in Human Embryonic Stem Cells Produces a Network of Excitatory and Inhibitory Neurons”. The FASEB Journal 33 (4): 5287–5299.